Infectious Disease Respiratory General Medicine Strong — NICE NG33 / WHO 2018
Mantoux Test / TST Interpretation (TB)
Tuberculin Skin Test (Mantoux) interpretation for latent TB infection (LTBI) screening. Induration threshold varies by risk group per NICE / WHO.
References
- NICE NG33. Tuberculosis: prevention, diagnosis, management and service organisation. 2016 (updated 2019).
- WHO. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. 2018.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Tetracosactide · Synthetic ACTH (short Synacthen test)
- Urea (13C) · 13C-urea breath test
- Isoniazid · Anti-Tuberculosis Antibiotic
- Tuberculin purified protein derivative · Mycobacterial antigen for delayed-type hypersensitivity testing
- Aminosalicylic Acid (Para-aminosalicylic acid, PAS) · Antimycobacterial (Anti-tuberculosis Agent)
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.